New COVID-19 data integration projects show the power of data sharing to address a public health crisis like the COVID-19 pandemic. NCATS’ new online resources describe NCATS work that brings a translational science approach to addressing COVID-19.
The COVID-19 pandemic has highlighted the urgent need for translational science. In the preclinical and clinical realms, NCATS researchers and partners have initiated numerous projects to explore therapeutic options for COVID-19.
As the COVID-19 pandemic rapidly evolves, NCATS is providing maximum flexibility to address funding, reporting and deadline issues for grantees, and harnessing the might of the CTSA Program, NTU program and more to help address the pandemic.
The Director of NCATS shares how an unexpected exchange helped spur the creation of the NCATS Pharmaceutical Collection, a compilation of every drug approved for human use by major regulatory agencies worldwide.
Christopher P. Austin, M.D., shares how his encounter with an end-stage ALS patient shaped his understanding of the personal and public health benefits of translating scientific discoveries into new treatments for people with rare diseases